Theriva Biologics
TOVX
TOVX
32 hedge funds and large institutions have $3.18M invested in Theriva Biologics in 2022 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
11% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 9
Holders
32
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$80K | |
| 2 | +$43.2K | |
| 3 | +$38K | |
| 4 |
HF
HRT Financial
New York
|
+$29K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$26K |
Top Sellers
| 1 | -$299K | |
| 2 | -$76K | |
| 3 | -$65.9K | |
| 4 |
IA
IFP Advisors
Tampa,
Florida
|
-$34.7K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$20K |